Sevirumab


Entry
D05831                      Drug                                   
Name
Sevirumab (USAN/INN)
Efficacy
Antiviral
Comment
Monoclonal antibody
Target
HCMV glycoprotein H [KO:K22777]
  Pathway
ko05163  Human cytomegalovirus infection
Brite
Antimicrobials [BR:br08307]
 Antivirals
  Entry, fusion or uncoating inhibitor
   Herpesvirus glycoprotein
    D05831  Sevirumab (USAN/INN)
Other DBs
CAS: 138660-96-5
PubChem: 47207492